facts about semaglutide India has over 135 million people living with obesity, and globally the number exceeds 1 billion (WHO). GLP-1 medications like Semaglutide (Ozempic®, Wegovy®) are reshaping the conversation around obesity today An Ongoing Crisis: Semaglutide Shortage

This is a dramatic reduction from the $1,000+ per month list price

Trial highlights: - Weight reduction: Patients achieved up to ~24% mean body weight loss at 48 weeks

Special considerations for different populations Not all semaglutide users have the same calorie needs

Behavior still matters

Molecular Protection & Barrier Shield: Provides a protective lipid-matrix "shield" that maintains the molecular integrity of the fragile copper peptides, ensuring maximum potency and bioavailability

Semaglutides mechanism of action, targeting appetite regulation, gastric emptying, and energy expenditure, offers a promising path toward your weight loss goals